| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Lysine 6-Oxidase | 46 | 2020 | 67 | 6.000 |
Why?
|
| Amino Acid Oxidoreductases | 22 | 2015 | 35 | 3.530 |
Why?
|
| Extracellular Matrix | 9 | 2020 | 115 | 1.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 12 | 2013 | 168 | 1.020 |
Why?
|
| Epithelial Cells | 5 | 2014 | 384 | 0.900 |
Why?
|
| Cell Differentiation | 3 | 2020 | 587 | 0.860 |
Why?
|
| Signal Transduction | 6 | 2020 | 1908 | 0.760 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2015 | 178 | 0.730 |
Why?
|
| Malvaceae | 1 | 2019 | 4 | 0.710 |
Why?
|
| Cell Communication | 1 | 2020 | 97 | 0.690 |
Why?
|
| Inflammation | 2 | 2019 | 618 | 0.680 |
Why?
|
| Molecular Sequence Data | 22 | 2008 | 1568 | 0.660 |
Why?
|
| Chromosome Mapping | 11 | 2007 | 188 | 0.640 |
Why?
|
| Elastin | 11 | 2006 | 40 | 0.630 |
Why?
|
| Membrane Proteins | 3 | 2008 | 517 | 0.620 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 149 | 0.610 |
Why?
|
| Plant Extracts | 2 | 2019 | 286 | 0.610 |
Why?
|
| Alopecia | 2 | 2008 | 9 | 0.580 |
Why?
|
| Phenotype | 9 | 2013 | 689 | 0.580 |
Why?
|
| Skin | 5 | 2005 | 174 | 0.570 |
Why?
|
| Skin Diseases | 2 | 2007 | 31 | 0.550 |
Why?
|
| Head and Neck Neoplasms | 4 | 2015 | 78 | 0.540 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2004 | 46 | 0.540 |
Why?
|
| Amino Acid Sequence | 14 | 2008 | 1180 | 0.530 |
Why?
|
| Humans | 72 | 2024 | 37093 | 0.510 |
Why?
|
| Exfoliation Syndrome | 1 | 2014 | 13 | 0.490 |
Why?
|
| Immunohistochemistry | 14 | 2010 | 893 | 0.480 |
Why?
|
| Animals | 40 | 2020 | 15081 | 0.460 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2014 | 74 | 0.460 |
Why?
|
| Speech Disorders | 1 | 2013 | 3 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2015 | 807 | 0.460 |
Why?
|
| Language Disorders | 1 | 2013 | 6 | 0.450 |
Why?
|
| Language Development | 1 | 2013 | 24 | 0.450 |
Why?
|
| Mutation | 9 | 2011 | 1095 | 0.440 |
Why?
|
| RNA, Messenger | 18 | 2012 | 1207 | 0.440 |
Why?
|
| Myocardium | 3 | 2004 | 235 | 0.430 |
Why?
|
| Mice | 25 | 2015 | 5913 | 0.420 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 120 | 0.420 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 105 | 0.420 |
Why?
|
| Central Nervous System | 2 | 2004 | 135 | 0.400 |
Why?
|
| Cytoplasm | 3 | 2006 | 143 | 0.390 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 219 | 0.380 |
Why?
|
| Cell Line | 8 | 2019 | 1354 | 0.380 |
Why?
|
| Enzyme Activation | 4 | 2007 | 444 | 0.370 |
Why?
|
| Cell Polarity | 2 | 2011 | 54 | 0.370 |
Why?
|
| Up-Regulation | 4 | 2008 | 513 | 0.370 |
Why?
|
| Base Sequence | 16 | 2008 | 997 | 0.360 |
Why?
|
| DNA, Complementary | 8 | 2005 | 191 | 0.340 |
Why?
|
| Blotting, Northern | 9 | 2007 | 150 | 0.340 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 4 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 7 | 2008 | 515 | 0.330 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2008 | 8 | 0.330 |
Why?
|
| Laryngeal Neoplasms | 1 | 2008 | 11 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2007 | 286 | 0.320 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2007 | 19 | 0.320 |
Why?
|
| Paxillin | 1 | 2007 | 6 | 0.310 |
Why?
|
| Breast Neoplasms | 9 | 2014 | 1502 | 0.310 |
Why?
|
| Epidermis | 2 | 2004 | 24 | 0.300 |
Why?
|
| Cell Movement | 6 | 2014 | 571 | 0.300 |
Why?
|
| Exons | 9 | 2001 | 88 | 0.300 |
Why?
|
| Hair Diseases | 1 | 2007 | 5 | 0.290 |
Why?
|
| Blotting, Western | 7 | 2009 | 859 | 0.290 |
Why?
|
| Placental Lactogen | 1 | 2006 | 8 | 0.290 |
Why?
|
| Superoxide Dismutase | 3 | 2004 | 155 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 75 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2007 | 6 | 0.280 |
Why?
|
| Skin Aging | 2 | 2005 | 10 | 0.280 |
Why?
|
| Transcription, Genetic | 8 | 2008 | 578 | 0.280 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 111 | 0.280 |
Why?
|
| Female | 37 | 2023 | 20969 | 0.270 |
Why?
|
| Williams Syndrome | 4 | 2000 | 4 | 0.270 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 127 | 0.270 |
Why?
|
| Protein Structure, Tertiary | 6 | 2005 | 408 | 0.270 |
Why?
|
| Fibronectins | 2 | 2005 | 66 | 0.270 |
Why?
|
| Breast | 1 | 2006 | 135 | 0.260 |
Why?
|
| Genetic Markers | 4 | 2001 | 142 | 0.260 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 251 | 0.260 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 186 | 0.250 |
Why?
|
| Cyclosporine | 2 | 2004 | 27 | 0.250 |
Why?
|
| Elastic Tissue | 2 | 2007 | 7 | 0.250 |
Why?
|
| Cell Line, Tumor | 9 | 2011 | 2231 | 0.250 |
Why?
|
| Astrocytes | 1 | 2007 | 255 | 0.250 |
Why?
|
| Collagen | 6 | 2009 | 172 | 0.250 |
Why?
|
| Gene Deletion | 3 | 2000 | 166 | 0.240 |
Why?
|
| Introns | 6 | 2001 | 75 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2009 | 623 | 0.240 |
Why?
|
| Fibroblasts | 5 | 2010 | 272 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2007 | 27 | 0.230 |
Why?
|
| Male | 27 | 2023 | 20025 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 10 | 2010 | 448 | 0.220 |
Why?
|
| Gene Expression | 5 | 2002 | 674 | 0.220 |
Why?
|
| Disease Models, Animal | 8 | 2012 | 1371 | 0.220 |
Why?
|
| Brain Ischemia | 2 | 2001 | 184 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2004 | 245 | 0.210 |
Why?
|
| Polymorphism, Genetic | 3 | 2001 | 191 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2002 | 10 | 0.210 |
Why?
|
| Cysteine | 2 | 2003 | 98 | 0.210 |
Why?
|
| Nitrogen Oxides | 1 | 2001 | 5 | 0.210 |
Why?
|
| Receptors, Lipoprotein | 1 | 2001 | 4 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2001 | 7 | 0.200 |
Why?
|
| Students, Medical | 1 | 2024 | 130 | 0.200 |
Why?
|
| Placenta | 3 | 2013 | 97 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 628 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 10 | 0.200 |
Why?
|
| Microsatellite Repeats | 6 | 2007 | 59 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2012 | 67 | 0.200 |
Why?
|
| Fibrosis | 4 | 2010 | 159 | 0.200 |
Why?
|
| Abortion, Induced | 1 | 2023 | 85 | 0.190 |
Why?
|
| Uterus | 1 | 2001 | 55 | 0.190 |
Why?
|
| Insect Proteins | 1 | 2001 | 50 | 0.190 |
Why?
|
| Leukocytes | 1 | 2001 | 72 | 0.190 |
Why?
|
| Transcription Factors | 5 | 2008 | 681 | 0.190 |
Why?
|
| Tropoelastin | 4 | 2007 | 13 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 5 | 2014 | 661 | 0.190 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 76 | 0.190 |
Why?
|
| Trans-Activators | 1 | 2001 | 174 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 43 | 0.180 |
Why?
|
| Cadherins | 2 | 2014 | 90 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 12 | 0.180 |
Why?
|
| Catalysis | 4 | 2009 | 179 | 0.170 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 171 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 70 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1015 | 0.170 |
Why?
|
| Models, Genetic | 4 | 2005 | 172 | 0.170 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1999 | 2 | 0.170 |
Why?
|
| Procollagen | 1 | 1999 | 4 | 0.170 |
Why?
|
| Aminopropionitrile | 6 | 2013 | 13 | 0.170 |
Why?
|
| Ischemic Attack, Transient | 3 | 2003 | 20 | 0.160 |
Why?
|
| Tissue Distribution | 4 | 2004 | 207 | 0.160 |
Why?
|
| DNA Primers | 4 | 2007 | 286 | 0.160 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 220 | 0.160 |
Why?
|
| Microscopy, Confocal | 4 | 2008 | 218 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 2007 | 87 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 6 | 2014 | 1609 | 0.150 |
Why?
|
| Cytokines | 2 | 2019 | 602 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 356 | 0.150 |
Why?
|
| Dinucleotide Repeats | 1 | 1997 | 2 | 0.150 |
Why?
|
| Connective Tissue Diseases | 1 | 1997 | 5 | 0.150 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 626 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 5 | 2010 | 474 | 0.150 |
Why?
|
| Lysine | 3 | 2005 | 113 | 0.150 |
Why?
|
| NF-kappa B | 1 | 2019 | 339 | 0.140 |
Why?
|
| Heterozygote | 3 | 2011 | 93 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 441 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2008 | 212 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2005 | 269 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2007 | 53 | 0.140 |
Why?
|
| Macrophages | 1 | 2019 | 439 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 80 | 0.130 |
Why?
|
| Adult | 11 | 2023 | 11712 | 0.130 |
Why?
|
| Rats | 10 | 2004 | 3483 | 0.130 |
Why?
|
| Hominidae | 1 | 1995 | 11 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Loss of Heterozygosity | 2 | 2007 | 19 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 252 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 485 | 0.120 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1997 | 28 | 0.120 |
Why?
|
| Drosophila | 3 | 2011 | 144 | 0.120 |
Why?
|
| Placentation | 1 | 2013 | 7 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2008 | 29 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2013 | 24 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 4 | 2008 | 251 | 0.120 |
Why?
|
| Armadillo Domain Proteins | 2 | 2005 | 3 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 172 | 0.120 |
Why?
|
| Plasmids | 2 | 2003 | 246 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 515 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2004 | 617 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2013 | 53 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2007 | 75 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 159 | 0.110 |
Why?
|
| Nerve Degeneration | 3 | 2003 | 107 | 0.110 |
Why?
|
| Yersinia enterocolitica | 1 | 1992 | 2 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1992 | 12 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 114 | 0.110 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 9 | 0.110 |
Why?
|
| Aged | 6 | 2007 | 6741 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 17 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 197 | 0.110 |
Why?
|
| Pregnancy | 7 | 2023 | 1549 | 0.100 |
Why?
|
| Mammary Glands, Human | 2 | 2009 | 39 | 0.100 |
Why?
|
| Survival Rate | 3 | 2001 | 311 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2015 | 435 | 0.100 |
Why?
|
| Lung | 3 | 2007 | 446 | 0.100 |
Why?
|
| GATA3 Transcription Factor | 1 | 2011 | 4 | 0.100 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2011 | 2 | 0.100 |
Why?
|
| Transfection | 3 | 2008 | 523 | 0.100 |
Why?
|
| DNA Replication | 1 | 1992 | 152 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2011 | 20 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2011 | 51 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2011 | 48 | 0.100 |
Why?
|
| Expressed Sequence Tags | 2 | 2001 | 27 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2003 | 453 | 0.100 |
Why?
|
| Rats, Wistar | 5 | 2003 | 233 | 0.100 |
Why?
|
| Amine Oxidase (Copper-Containing) | 2 | 2008 | 5 | 0.100 |
Why?
|
| Hyperglycemia | 2 | 2003 | 55 | 0.100 |
Why?
|
| Azacitidine | 2 | 2009 | 22 | 0.100 |
Why?
|
| Dogs | 2 | 2014 | 149 | 0.100 |
Why?
|
| DNA | 4 | 2008 | 574 | 0.100 |
Why?
|
| Binding Sites | 3 | 2001 | 651 | 0.100 |
Why?
|
| Dermis | 1 | 2010 | 8 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2012 | 134 | 0.090 |
Why?
|
| Antigens, Neoplasm | 2 | 2008 | 59 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2008 | 15 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 1103 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2001 | 85 | 0.090 |
Why?
|
| Brain | 3 | 2003 | 1346 | 0.090 |
Why?
|
| Pseudoxanthoma Elasticum | 2 | 2000 | 32 | 0.090 |
Why?
|
| Integrins | 1 | 2009 | 51 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 93 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1039 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2001 | 268 | 0.080 |
Why?
|
| Middle Aged | 7 | 2008 | 10129 | 0.080 |
Why?
|
| Glutathione Transferase | 2 | 2008 | 88 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 3 | 1999 | 23 | 0.080 |
Why?
|
| Hydrogen Peroxide | 2 | 2008 | 190 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 70 | 0.080 |
Why?
|
| Genes | 3 | 1999 | 60 | 0.080 |
Why?
|
| Child | 4 | 2007 | 3131 | 0.080 |
Why?
|
| Malaria Vaccines | 1 | 2008 | 21 | 0.080 |
Why?
|
| Pedigree | 5 | 2000 | 79 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2007 | 4 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2007 | 4 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2007 | 14 | 0.080 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 5 | 0.080 |
Why?
|
| Mesoderm | 1 | 2007 | 70 | 0.070 |
Why?
|
| Sebaceous Glands | 1 | 2007 | 3 | 0.070 |
Why?
|
| Gene Library | 2 | 1999 | 57 | 0.070 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 9 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2008 | 113 | 0.070 |
Why?
|
| Muscle, Smooth | 2 | 2005 | 58 | 0.070 |
Why?
|
| CpG Islands | 1 | 2007 | 97 | 0.070 |
Why?
|
| Pelvis | 1 | 2007 | 14 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2007 | 32 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 22 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2005 | 502 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2008 | 95 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2007 | 66 | 0.070 |
Why?
|
| Postpartum Period | 1 | 2007 | 66 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2007 | 894 | 0.070 |
Why?
|
| Aspergillus nidulans | 1 | 2006 | 7 | 0.070 |
Why?
|
| Germination | 1 | 2006 | 7 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 295 | 0.070 |
Why?
|
| Morinda | 1 | 2006 | 9 | 0.070 |
Why?
|
| Blood | 1 | 2006 | 37 | 0.070 |
Why?
|
| Cell Division | 1 | 2006 | 307 | 0.070 |
Why?
|
| Progeria | 1 | 2005 | 9 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2005 | 11 | 0.070 |
Why?
|
| Myoblasts | 1 | 2005 | 27 | 0.070 |
Why?
|
| Euchromatin | 1 | 2005 | 6 | 0.070 |
Why?
|
| Salivary Glands | 1 | 2005 | 12 | 0.060 |
Why?
|
| Kinetics | 2 | 2005 | 708 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 188 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 50 | 0.060 |
Why?
|
| Pericytes | 1 | 2005 | 22 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 59 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 2 | 2002 | 12 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 539 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 99 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 176 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 201 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2005 | 90 | 0.060 |
Why?
|
| Organ Specificity | 2 | 1995 | 129 | 0.060 |
Why?
|
| Protein Binding | 2 | 2005 | 972 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2015 | 933 | 0.060 |
Why?
|
| 5' Untranslated Regions | 2 | 2001 | 18 | 0.060 |
Why?
|
| Muscle Weakness | 1 | 2004 | 7 | 0.060 |
Why?
|
| Reperfusion Injury | 2 | 2003 | 57 | 0.060 |
Why?
|
| Carcinoma | 1 | 2005 | 96 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 610 | 0.060 |
Why?
|
| Genome | 1 | 2005 | 125 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 130 | 0.060 |
Why?
|
| Propidium | 1 | 2004 | 19 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2001 | 207 | 0.060 |
Why?
|
| Candida albicans | 1 | 2006 | 164 | 0.060 |
Why?
|
| Saliva | 1 | 2005 | 107 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1130 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 129 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 116 | 0.060 |
Why?
|
| Chromatin | 1 | 2005 | 169 | 0.060 |
Why?
|
| Chorion | 2 | 2001 | 8 | 0.060 |
Why?
|
| Decidua | 2 | 2001 | 8 | 0.060 |
Why?
|
| Amnion | 2 | 2001 | 16 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1999 | 325 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2000 | 8 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 180 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 2379 | 0.060 |
Why?
|
| Forecasting | 1 | 2024 | 128 | 0.060 |
Why?
|
| Cell Survival | 2 | 2004 | 864 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2001 | 90 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2015 | 343 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 2 | 2006 | 45 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 54 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 381 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2001 | 389 | 0.050 |
Why?
|
| Longevity | 1 | 2004 | 147 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2015 | 1518 | 0.050 |
Why?
|
| Religion | 1 | 2023 | 87 | 0.050 |
Why?
|
| Sunlight | 1 | 2002 | 47 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 69 | 0.050 |
Why?
|
| Spin Trapping | 1 | 2001 | 1 | 0.050 |
Why?
|
| Linear Models | 1 | 2023 | 275 | 0.050 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2001 | 8 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2001 | 15 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2001 | 18 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2001 | 17 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 94 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2001 | 77 | 0.050 |
Why?
|
| Neurons | 3 | 2004 | 1175 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 61 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2001 | 13 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 74 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2001 | 9 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 91 | 0.050 |
Why?
|
| Genes, Duplicate | 1 | 2001 | 4 | 0.050 |
Why?
|
| Colon | 1 | 2002 | 103 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2001 | 6 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2001 | 119 | 0.050 |
Why?
|
| beta Catenin | 1 | 2001 | 48 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 92 | 0.050 |
Why?
|
| Crossing Over, Genetic | 2 | 1999 | 5 | 0.050 |
Why?
|
| Rubiaceae | 1 | 2000 | 2 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2002 | 1492 | 0.050 |
Why?
|
| Glycosides | 1 | 2000 | 21 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2001 | 78 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2007 | 1418 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2007 | 173 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 7 | 0.040 |
Why?
|
| Trisaccharides | 1 | 1999 | 10 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 1999 | 14 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2001 | 291 | 0.040 |
Why?
|
| Hawaii | 2 | 2024 | 1929 | 0.040 |
Why?
|
| Citrus | 1 | 1999 | 15 | 0.040 |
Why?
|
| Relaxin | 1 | 1999 | 10 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 2000 | 68 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2003 | 212 | 0.040 |
Why?
|
| Glucose | 1 | 2001 | 230 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2000 | 81 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2000 | 83 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2001 | 121 | 0.040 |
Why?
|
| Carbon Tetrachloride | 1 | 1999 | 7 | 0.040 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1999 | 3 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1455 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 1999 | 29 | 0.040 |
Why?
|
| Fruit | 1 | 2000 | 173 | 0.040 |
Why?
|
| Fatty Acids | 1 | 1999 | 127 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 1999 | 52 | 0.040 |
Why?
|
| Fibrin | 1 | 1998 | 10 | 0.040 |
Why?
|
| Schistosomiasis mansoni | 1 | 1998 | 8 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 4 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 1998 | 30 | 0.040 |
Why?
|
| Stromal Cells | 1 | 1998 | 49 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 1998 | 31 | 0.040 |
Why?
|
| Extraembryonic Membranes | 1 | 1997 | 6 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2001 | 808 | 0.040 |
Why?
|
| Cattle | 2 | 1998 | 477 | 0.040 |
Why?
|
| Mitochondria | 1 | 2001 | 487 | 0.040 |
Why?
|
| RNA | 1 | 1999 | 241 | 0.040 |
Why?
|
| Alleles | 2 | 1999 | 321 | 0.040 |
Why?
|
| Biopsy | 2 | 2010 | 164 | 0.040 |
Why?
|
| Meiosis | 1 | 1996 | 62 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1997 | 130 | 0.030 |
Why?
|
| Homozygote | 2 | 2011 | 77 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 479 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 1996 | 26 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 48 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 45 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1996 | 265 | 0.030 |
Why?
|
| Gestational Age | 2 | 2007 | 190 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 52 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 26 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 1995 | 7 | 0.030 |
Why?
|
| Genotype | 4 | 2000 | 730 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1995 | 47 | 0.030 |
Why?
|
| CHO Cells | 1 | 1995 | 124 | 0.030 |
Why?
|
| Cricetinae | 1 | 1995 | 238 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1997 | 387 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 17 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1995 | 128 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 358 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1993 | 24 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1993 | 17 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 431 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 133 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 50 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 151 | 0.030 |
Why?
|
| 3T3 Cells | 2 | 2008 | 59 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 337 | 0.030 |
Why?
|
| Chlorpromazine | 1 | 1992 | 3 | 0.030 |
Why?
|
| Methylene Blue | 1 | 1992 | 5 | 0.030 |
Why?
|
| Promethazine | 1 | 1992 | 2 | 0.030 |
Why?
|
| Imipramine | 1 | 1992 | 8 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 1992 | 12 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2004 | 143 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 302 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1993 | 118 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 41 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 664 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 601 | 0.030 |
Why?
|
| Cytochrome c Group | 2 | 2003 | 16 | 0.030 |
Why?
|
| Cannabinoids | 1 | 1992 | 56 | 0.030 |
Why?
|
| Dentate Gyrus | 2 | 2003 | 39 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2012 | 97 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1992 | 186 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2011 | 28 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2011 | 16 | 0.030 |
Why?
|
| Copper | 2 | 2003 | 105 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 129 | 0.020 |
Why?
|
| Thiophenes | 1 | 2011 | 31 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1992 | 409 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1992 | 492 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2010 | 47 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2011 | 118 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 69 | 0.020 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 2 | 2000 | 7 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2000 | 37 | 0.020 |
Why?
|
| Glucosides | 2 | 2000 | 16 | 0.020 |
Why?
|
| Elasticity | 2 | 2002 | 38 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 106 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 25 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 98 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 68 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 32 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2008 | 9 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 739 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2000 | 289 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2008 | 35 | 0.020 |
Why?
|
| Leukoplakia, Oral | 1 | 2008 | 11 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2008 | 34 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 65 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 58 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2008 | 20 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2008 | 86 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 21 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 148 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 82 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 84 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2007 | 7 | 0.020 |
Why?
|
| Prolapse | 1 | 2007 | 2 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 76 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2007 | 26 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 39 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 31 | 0.020 |
Why?
|
| Sheep | 1 | 2007 | 72 | 0.020 |
Why?
|
| Operon | 1 | 1987 | 44 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 21 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 399 | 0.020 |
Why?
|
| Peroxidase | 1 | 2007 | 49 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 75 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 250 | 0.020 |
Why?
|
| Vagina | 1 | 2007 | 81 | 0.020 |
Why?
|
| Cyanobacteria | 1 | 1987 | 23 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 234 | 0.020 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2005 | 9 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 161 | 0.020 |
Why?
|
| Plant Proteins | 1 | 1987 | 93 | 0.020 |
Why?
|
| Culture Media | 1 | 2006 | 90 | 0.020 |
Why?
|
| Oxygen | 1 | 2007 | 207 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2001 | 31 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 306 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2005 | 43 | 0.020 |
Why?
|
| Catalase | 1 | 2005 | 109 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 126 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 131 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 189 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1198 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 128 | 0.020 |
Why?
|
| Actins | 1 | 2005 | 148 | 0.020 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 5 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 64 | 0.020 |
Why?
|
| Hindlimb | 1 | 2004 | 27 | 0.020 |
Why?
|
| RNA Interference | 1 | 2005 | 243 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2004 | 44 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 153 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1046 | 0.010 |
Why?
|
| Benzylamines | 1 | 2003 | 6 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2003 | 12 | 0.010 |
Why?
|
| Proteins | 1 | 1987 | 369 | 0.010 |
Why?
|
| Quinones | 1 | 2003 | 14 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2003 | 70 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2003 | 25 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 117 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2003 | 21 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 265 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 127 | 0.010 |
Why?
|
| Ear, External | 1 | 2002 | 2 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 78 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 39 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 212 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 286 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 434 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 540 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 161 | 0.010 |
Why?
|
| Cell Death | 1 | 2003 | 267 | 0.010 |
Why?
|
| Neocortex | 1 | 2001 | 27 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 418 | 0.010 |
Why?
|
| Thalamus | 1 | 2001 | 30 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2001 | 8 | 0.010 |
Why?
|
| Abortion, Legal | 1 | 2001 | 6 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2001 | 35 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2001 | 18 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1033 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 209 | 0.010 |
Why?
|
| Optical Rotation | 1 | 2000 | 1 | 0.010 |
Why?
|
| Caspases | 1 | 2001 | 147 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2000 | 37 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 50 | 0.010 |
Why?
|
| Consanguinity | 1 | 2000 | 5 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 93 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4268 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 433 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 81 | 0.010 |
Why?
|
| TATA Box | 1 | 1999 | 4 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1999 | 2 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1999 | 20 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 9 | 0.010 |
Why?
|
| Rutin | 1 | 1999 | 3 | 0.010 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1999 | 7 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2001 | 104 | 0.010 |
Why?
|
| Pyrans | 1 | 1999 | 10 | 0.010 |
Why?
|
| Pseudogenes | 1 | 1999 | 11 | 0.010 |
Why?
|
| Esters | 1 | 1999 | 28 | 0.010 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2000 | 48 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 42 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 928 | 0.010 |
Why?
|
| Response Elements | 1 | 1999 | 56 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1742 | 0.010 |
Why?
|
| Multigene Family | 1 | 1999 | 106 | 0.010 |
Why?
|
| Computational Biology | 1 | 2001 | 293 | 0.010 |
Why?
|
| Compliance | 1 | 1999 | 9 | 0.010 |
Why?
|
| Haplotypes | 1 | 1999 | 182 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1999 | 40 | 0.010 |
Why?
|
| Liver Diseases, Parasitic | 1 | 1998 | 1 | 0.010 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1998 | 2 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 561 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 935 | 0.010 |
Why?
|
| Desmosine | 1 | 1997 | 1 | 0.010 |
Why?
|
| Luciferases | 1 | 1997 | 63 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 142 | 0.010 |
Why?
|
| Haploidy | 1 | 1996 | 16 | 0.010 |
Why?
|
| Drug Stability | 1 | 1997 | 116 | 0.010 |
Why?
|
| Hela Cells | 1 | 1998 | 366 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 5363 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1997 | 195 | 0.010 |
Why?
|
| Amino Acids | 1 | 1997 | 145 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 167 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2000 | 767 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 308 | 0.010 |
Why?
|
| Apoptosis | 1 | 2001 | 1398 | 0.010 |
Why?
|
| RNA Caps | 1 | 1993 | 13 | 0.010 |
Why?
|
| Poly A | 1 | 1993 | 33 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1618 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1987 | 26 | 0.000 |
Why?
|
| Gases | 1 | 1987 | 24 | 0.000 |
Why?
|